Transient, Unexplained, and Psychogenic Visual Loss in Children

  • Michael C. Brodsky


Some children have visual disturbances that occur in the absence of, or are out of proportion to, their objective ophthalmological findings. These symptoms reflect a wide range of processes that may be benign or a sign of neurological, systemic, or psychiatric disease. This chapter deals with the neuro-ophthalmologic detection of organic and psychogenic disorders that may manifest as transient or unexplained visual loss, along with other episodic visual disturbances that occur in childhood. In these cases, several formidable problems confront the physician who is trying to reach the correct diagnosis. The descriptions of episodic visual disturbances and hallucinations in children are generally less complex in detail than those in the adult population because children have a limited vocabulary and a limited experiential basis of sensory phenomena to draw upon.


Posterior Reversible Encephalopathy Syndrome Visual Hallucination Cortical Spreading Depression Transient Global Amnesia Zolmitriptan Nasal Spray 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry. 1983;40:884–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Abu-Arafeh I, Callaghan M. Short migraine attacks of less than 2 h duration in children and adolescents. Cephalalgia. 2004;24:333–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Abu-Arafeh I, Russell G. Prevalence of headache in schoolchildren. Br Med J. 1994;309:765–9.CrossRefGoogle Scholar
  4. 4.
    Adcock JE, Panayiotopoulos CP. Occipital lobe seizures and epilepsies. J Clin Neurophysiol. 2012;29:397–407.PubMedCrossRefGoogle Scholar
  5. 5.
    Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomography study in spontaneous migraine. Arch Neurol. 2005;62:1270–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005;128:932–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Ahn SJ, Ahn J, Park KH, Woo SJ. Multimodal imaging of occult macular dystrophy. JAMA Ophthalmol. 2013;131:880–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Aicardi J. Diseases of the Nervous System in Childhood. 2nd ed. London: Mackeith Press; 1998.Google Scholar
  9. 9.
    Aicardi J, Bourgeois M, Goutieres F. Alternating hemiplegia of childhood: clinical findings and diagnostic criteria. In: Andermann F, Aicardi J, Vigevano F, editors. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995. p. 3–18.Google Scholar
  10. 10.
    Airy H. On a distinct form of transient hemiopsia. Philos Trans R Soc Lond B Biol Sci. 1870;160:247–64.CrossRefGoogle Scholar
  11. 11.
    Akin R, Ünay B, Sarici SU, Ulaş U, Gökçay. Evaluation of visual evoked potentials in children with headache. Turk J Pediatr. 2005;47:150–2.PubMedGoogle Scholar
  12. 12.
    Aldrich MS, Vanderzant CW, Alessi AG, Abou-Khalil B, Sackellares JC. Ictal cortical blindness with permanent visual loss. Epilepsia. 1989;30:116–20.PubMedCrossRefGoogle Scholar
  13. 13.
    Alvarez WC. The migrainous scotoma as studied in 618 persons. Am J Ophthalmol. 1960;49:489–504.PubMedCrossRefGoogle Scholar
  14. 14.
    Ambrosini A, D’Onofrio M, Grieco GS, et al. Familiar basilar migraine associated with a new mutation in the ATPA2 gene. Neurology. 2005;65:1826–8.PubMedCrossRefGoogle Scholar
  15. 15.
    American Council on Headache Education with Lynne M. Constantine and Suzanne Scott. Migraine: The Complete Guide: A Comprehensive Resource Book for People with Migraine, Their Families, and Physicians. New York: Dell Publishing; 1994. p. 51.Google Scholar
  16. 16.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed (rev). Washington, DC: American Psychiatric Association; 2015.Google Scholar
  17. 17.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
  18. 18.
    Amery WK, Waelkens J, Vandenbergh V. The sensorium of the migraineur. Ital J Neurol Sci. 1988;9:539–45.PubMedCrossRefGoogle Scholar
  19. 19.
    Andermann FA. Migraine and epilepsy: an overview. In: Andermann FA, Lugaresi E, editors. Migraine and Epilepsy. Boston: Butterworths; 1987. p. 281–91.Google Scholar
  20. 20.
    Andersson KE, Vinge E. Beta-adrenoreceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs. 1990;39:355–73.PubMedCrossRefGoogle Scholar
  21. 21.
    Appleton R, Farrell K, Buncic JR, Hill A. Amaurosis fugax in teenagers: a migraine variant. Am J Dis Child. 1988;142:331–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Arffa RC. Grayson’s Diseases of the Cornea. 3rd ed. St Louis: C.V. Mosby; 1991. p. 401–16.Google Scholar
  23. 23.
    Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology. 2012;79:1881–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Artman M, Grayson M, Boerth RC. Propranolol in children: safety-toxicity. Pediatrics. 1982;70:30–1.PubMedGoogle Scholar
  25. 25.
    Aschwanden C. Experts question placebo pill for children. New York Times; May 27; 2008; D5, D7.Google Scholar
  26. 26.
    Asghar SJ, Milesi-Hallé A, Kaushik C, Glasier C, Sharp GB. Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children. Pediatr Neurol. 2012;47:201–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Ashkenazi S, Bellah G, Cleary TG. Hallucinations as an initial manifestation of shigellosis. J Pediatr. 1989;114:95–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Aziz HA, Kheir WJ, Young RC, et al. Acute macular neuroretinopathy: a case report and review of the literature 2002-2012. Ophthalmic Surg Lasers Imaging Retina. 2015;46:112–4.CrossRefGoogle Scholar
  29. 29.
    Bahn CA. The psychoneurotic factor in ophthalmic practice. Am J Ophthalmol. 1943;26:369–78.CrossRefGoogle Scholar
  30. 30.
    Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet. 2001;357:1016–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008;24:321–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Bain KE, Beatty S, Lloyd C. Non-organic visual loss in children. Eye (Lond). 2000;14:700–2.CrossRefGoogle Scholar
  33. 33.
    Barabas G, Matthews WS, Ferrari M. Childhood migraine and motion sickness. Pediatrics. 1983;72:188–90.PubMedGoogle Scholar
  34. 34.
    Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990;8:817–28.PubMedGoogle Scholar
  35. 35.
    Barlow CF. Headaches and Migraine in Childhood. Oxford: Blackwell Scientific; 1984.Google Scholar
  36. 36.
    Barlow CF. Migraine in the infant and toddler. J Child Neurol. 1994;9:92–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Barsook D, May A, Goadsby PJ, Hargreaves R. The Migraine Brain: Imaging Structure and Function. New York: Oxford University Press; 2012.Google Scholar
  38. 38.
    Basser LS. Benign paroxysmal vertigo of childhood (a variant of vestibular neuronitis). Brain. 1964;87:141–52.PubMedCrossRefGoogle Scholar
  39. 39.
    Basser LS. The relation of migraine and epilepsy. Brain. 1969;92:258–300.CrossRefGoogle Scholar
  40. 40.
    Bender MB, Feldman M, Sobin AJ. Palinopsia. Brain. 1968;91:321–38.PubMedCrossRefGoogle Scholar
  41. 41.
    Benedik MP, Zaletel M, Meglič NP, et al. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Catheter Cardiovasc Interv. 2007;70:999–1007.PubMedCrossRefGoogle Scholar
  42. 42.
    Berman RJ. Psychogenic visual disorders in an abused child: a case report. Am J Optom Physiol Opt. 1978;55:735–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Bernard GA, Bennett JL. Vasospastic amaurosis fugax. Arch Ophthalmol. 1999;117:1568–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Besch D, Kurtenbach A, Apfelstedt-Sylla E, et al. Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol. 2002;104:151–70.PubMedCrossRefGoogle Scholar
  45. 45.
    Bickerstaff ER. Impairment of consciousness in migraine. Lancet. 1961;2:1057–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Bien CG, Benninger FO, Urbach H, Schramm J, Kurthen M, Elger CE. Localizing value of epileptic visual auras. Brain. 2000;123:244–53.Google Scholar
  47. 47.
    Bigley GK, Sharp FR. Reversible alexia without agraphia due to migraine. Arch Neurol. 1983;40:114–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Bille B. Migraine in school children. Acta Paediatr Scand. 1962;51 Suppl 36:1–151.Google Scholar
  49. 49.
    Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache. 1977;17:61–3.PubMedCrossRefGoogle Scholar
  50. 50.
    Biller J, Johnson MR, Adams HP, et al. Further observations on cerebral or retinal ischemia in patients with right-to-left intracardiac shunts. Arch Neurol. 1987;44:740–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Birnbach CD, Järveläinen M, Possin DE, Milam AH. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994;101:1211–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Binalsheikh IM, Griesemer D, Wang S, Alvarez-Altalef R. Lyme neuroborreliosis presenting as Alice in Wonderland syndrome. Pediatr Neurol. 2012;46:185–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Bourke RD, Gole GA. Detection of functional vision loss using the Ishihara plates. Aust N Z J Ophthalmol. 1994;22:115–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Boz PJ, Deutman AF. Acute macular neuroretinopathy. Am J Ophthalmol. 1975;80:573–84.CrossRefGoogle Scholar
  55. 55.
    Brandt T. A chameleon among the episodic vertigo syndromes: ‘migrainous vertigo’ or ‘vestibular migraine’. Cephalalgia. 2004;24:81–2.PubMedCrossRefGoogle Scholar
  56. 56.
    Brennan KC. Turn down the lights! An irritable occipital cortex in migraine without aura. Neurology. 2011;76:206–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Brighina F, Cosentino G, Fierro B. Brain stimulation in migraine. Handb Clin Neurol. 2013;116:585–98.PubMedCrossRefGoogle Scholar
  58. 58.
    Brigo F, Storti M, Nardone R, et al. Transcranial magnetic stimulation of the visual cortex in migraine patients: a systematic review with metaanalysis. J Headache Pain. 2012;13:339–49.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Brodsky MC. Contractile morning glory disc causing transient monocular blindness in a child. Arch Ophthalmol. 2006;124:1199–201.PubMedCrossRefGoogle Scholar
  60. 60.
    Brodsky MC, Liu GT. The twists and turns of optic disc swelling in a teenager. Surv Ophthalmol. 2013;58:273–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Bruen R, Peng SL, Perreault S, Major P, Ospina LH. Persistent migraine aura in an adolescent girl. J AAPOS. 2013;17:426–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Brust JC, Behrens MM. “Release hallucinations” as the major symptom of posterior cerebral artery occlusion: a report of 2 cases. Ann Neurol. 1977;2:432–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Burch EP. Psychoneurotic reaction patterns in ophthalmology. Trans Am Ophthalmol Soc. 1950;48:370–94.PubMedPubMedCentralGoogle Scholar
  64. 64.
    Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991;325:870–3.PubMedCrossRefGoogle Scholar
  65. 65.
    Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123:1703–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Byrd RL, Rohrbaugh TM, Raney Jr RB, Norris DG. Transient cortical blindness secondary to vincristine therapy in childhood malignancies. Cancer. 1981;47:37–40.PubMedCrossRefGoogle Scholar
  67. 67.
    Cai Y, Pulido JS. False-positive anti-retinal antibodies as a cause of psychogenic visual loss. Ocul Immunol Inflamm. 2014;22:330–2.PubMedCrossRefGoogle Scholar
  68. 68.
    Callanan D, Gass JD. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot syndrome and acute idiopathic blind spot enlargement. Ophthalmology. 1992;99:1678–85.PubMedCrossRefGoogle Scholar
  69. 69.
    Campbell JK. Manifestations of migraine. Neurol Clin. 1990;8:841–55.PubMedGoogle Scholar
  70. 70.
    Candee MS, McCandless RT, Moore KR, Arrington CB, Minich LL, Bale Jr JF. White matter lesions in children and adolescents with migraine. Pediatr Neurol. 2013;49:393–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Caplan LR. “Top of the basilar” syndrome. Neurology. 1980;30:72–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Caraballo RH, Cersósimo RO, Fejerman N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia. 2008;49:288–97.PubMedCrossRefGoogle Scholar
  73. 73.
    Caraballo R, Cersósimo R, Fejerman N. Panayiotopoulos syndrome: a prospective study of 192 patients. Epilepsia. 2007;48:1054–61.PubMedCrossRefGoogle Scholar
  74. 74.
    Carlow TJ. Oculomotor ophthalmoplegic migraine: is it really migraine? J Neuroophthalmol. 2002;22:215–21.PubMedCrossRefGoogle Scholar
  75. 75.
    Carlsson A, Forsgren L, Nylander P-O, et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-21.1. Neurology. 2002;59:1804–7.PubMedCrossRefGoogle Scholar
  76. 76.
    Catalono RA, Simon JW, Krohel GB, Rosenberg PN. Functional visual loss in children. Ophthalmology. 1986;93:385–90.PubMedCrossRefGoogle Scholar
  77. 77.
    Cavazzuti GB, Cappella L, Nalin A. Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia. 1980;21:43–55.PubMedCrossRefGoogle Scholar
  78. 78.
    Chary P, Rajendran B. Benign occipital seizures: natural progression and atypical evolution. Ann Indian Acad Neurol. 2013;16:556–60.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Chen CS, Lee AW, Karagiannis A, Crompton JL, Selva D. Practical clinical approaches to functional visual loss. J Clin Neurosci. 2007;14:1–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Chen W-T, Lin Y-Y, Fuh J-L, Hämäläinen MS, Ko Y-C, Wang S-J. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain. 2011;134:2387–95.Google Scholar
  81. 81.
    Chou YH, Wang PJ, Lin MY, Shen YZ, Lee CY. Acute hemiplegia in infancy and childhood. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1994;35:45–56.PubMedGoogle Scholar
  82. 82.
    Chu ML, Shinnar S. Headaches in children younger than 7 years of age. Arch Neurol. 1992;49:79–82.PubMedCrossRefGoogle Scholar
  83. 83.
    Chun HG, Leyland-Jones BR, Caryk SM, Hoth DF. Central nervous system toxicity of fludarabine phosphate. Cancer Treat Rep. 1986;70:1225–8.PubMedGoogle Scholar
  84. 84.
    Cleves C, Friedman NR, Rothner AD, Hussain MS. Genetically confirmed CADASIL in a pediatric patient. Pediatrics. 2010;126:e1603–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Cogan DJ. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973;188:139–50.PubMedCrossRefGoogle Scholar
  86. 86.
    Cohn R. Phantom vision. Arch Neurol. 1971;25:468–71.PubMedCrossRefGoogle Scholar
  87. 87.
    Cologno D, Torelli P, Manzoni GC. Transient visual disturbances during migraine without aura attacks. Headache. 2002;42:930–3.PubMedCrossRefGoogle Scholar
  88. 88.
    Congdon PJ, Forsythe WI. Migraine in childhood: a study of 300 children. Dev Med Child Neurol. 1979;21:209–16.CrossRefGoogle Scholar
  89. 89.
    Connelly M. Cognitive behavioral therapy for treatment of pediatric chronic migraine. JAMA. 2013;310:2617–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Copperman SM. “Alice in Wonderland” syndrome as a presenting symptom of infectious mononucleosis in children: a description of three affected young people. Clin Pediatr (Phila). 1977;16:143–6.CrossRefGoogle Scholar
  91. 91.
    Corbett JJ. Neuro-ophthalmic complications of migraine and cluster headaches. Neurol Clin. 1983;4:973–95.Google Scholar
  92. 92.
    Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979;36:695–9.PubMedCrossRefGoogle Scholar
  93. 93.
    Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118:e1237–43.PubMedCrossRefGoogle Scholar
  94. 94.
    Crevits L, Bosman T. Migraine-related vertigo: towards a distinctive entity. Clin Neurol Neurosurg. 2005;107:82–7.PubMedCrossRefGoogle Scholar
  95. 95.
    Critchley M. Types of visual perseveration: “palinopsia” and “illusory visual spread”. Brain. 1951;74:267–99.PubMedCrossRefGoogle Scholar
  96. 96.
    Cukras CA, Wong WT, Caruso R, Cunningham D, Zein W, Sieving PA. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch Ophthalmol. 2012;130:171–9.PubMedCrossRefGoogle Scholar
  97. 97.
    Cutrer FM. Migraine: does one size fit all? Curr Opin Neurol. 2003;16:315–7.PubMedCrossRefGoogle Scholar
  98. 98.
    Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2010;30:120–30.PubMedCrossRefGoogle Scholar
  99. 99.
    Cutrer FM, Huerter KP. Migraine aura. Neurologist. 2007;13:118–25.PubMedCrossRefGoogle Scholar
  100. 100.
    Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998;43:25–31.PubMedCrossRefGoogle Scholar
  101. 101.
    D’Andrea G, Toldo M, Cortelazzo S, Milone FF. Platelet activity in migraine. Headache. 1982;22:207–12.PubMedCrossRefGoogle Scholar
  102. 102.
    Daroff RB. Retinal migraine. J Neuroophthalmol. 2007;27:83.PubMedCrossRefGoogle Scholar
  103. 103.
    Davis FA, Bergen D, Schauf C, McDonald I, Deutsch W. Movement phosphenes in optic neuritis: a new clinical sign. Neurology. 1976;26:1100–4.PubMedCrossRefGoogle Scholar
  104. 104.
    De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33:192–6.PubMedCrossRefGoogle Scholar
  105. 105.
    Denuelle M, Boulloche N, Payoux P, Fabre N, Trotter Y, Géraud GA. PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213–8.PubMedCrossRefGoogle Scholar
  106. 106.
    Deonna T, Ziegler A-L, Despland PA. Paroxysmal visual disturbances of epileptic origin and occipital epilepsy in children. Neuropediatrics. 1984;15:131–5.PubMedCrossRefGoogle Scholar
  107. 107.
    Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;336:371–7.CrossRefGoogle Scholar
  108. 108.
    Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246:883–92.PubMedCrossRefGoogle Scholar
  109. 109.
    Digre KB. Light sensitivity in migraineurs. Headache. 2003;43:917–20.PubMedCrossRefGoogle Scholar
  110. 110.
    Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol. 2012;32:68–81.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varmer MW, Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol. 1989;25:228–32.PubMedCrossRefGoogle Scholar
  112. 112.
    Dobrovolny R, Liskova P, Ledvinova J, et al. Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation. Am J Ophthalmol. 2007;143:663–71.PubMedCrossRefGoogle Scholar
  113. 113.
    Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747–50.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Dooley JM, Augustine HF, Gordon KE, Brna PM, Westby E. Alice in Wonderland and other migraine associated phenomena—evolution over 30 years of headache diagnosis. Pediatr Neurol. 2014;51:321–3.PubMedCrossRefGoogle Scholar
  115. 115.
    Doyle E, Vote BJ, Casswell AG. Retinal migraine: caught in the act. Br J Ophthalmol. 2004;88:301–2.PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465–9.PubMedCrossRefGoogle Scholar
  117. 117.
    Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalalgia. 2002;22:117–24.PubMedCrossRefGoogle Scholar
  118. 118.
    Drummond PD. Photophobia and autonomic responses to facial pain in migraine. Brain. 1997;120:1857–64.PubMedCrossRefGoogle Scholar
  119. 119.
    Drummond PD, Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia. 1993;13:321–3.PubMedCrossRefGoogle Scholar
  120. 120.
    Duckro PN, Cantwell-Simmons EL. A review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache. 1989;29:428–33.PubMedCrossRefGoogle Scholar
  121. 121.
    Ducros A. Familial hemiplegic migraine: a model for the genetic studies of migraine. Cephalalgia. 2014;34:1035–7.PubMedCrossRefGoogle Scholar
  122. 122.
    Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17–24.PubMedCrossRefGoogle Scholar
  123. 123.
    Ducros A, Joutel A, Vahedi K, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 1997;42:885–90.PubMedCrossRefGoogle Scholar
  124. 124.
    Duncker T, Tsang SH, Lee W, et al. Quantitative fundus autofluorescence distinguishes ABCA4-associated bull’s eye maculopathy. Ophthalmology. 2015;122:345–55.PubMedCrossRefGoogle Scholar
  125. 125.
    Dunn DW, Weissberg LA, Nadell J. Peduncular hallucinosis caused by brainstem compression. Neurology. 1983;33:1360–1.PubMedCrossRefGoogle Scholar
  126. 126.
    Durkan GP, Troost BT, Slamovits TL, Spoor TC, Kennerdell JS. Recurrent painless oculomotor palsy in children. A variant of ophthalmoplegic migraine? Headache. 1981;21:58–62.PubMedCrossRefGoogle Scholar
  127. 127.
    Dutton GN, McKillop EC, Saidkasimova S. Visual problems as a result of brain damage in children. Br J Ophthalmol. 2006;90:932–3.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Dvorkin G, Andermann F, Melancon D, et al. Malignant migraine syndrome: classical migraine, occipital seizures, and alternating strokes. Neurology. 1984;34:245. Abstract.Google Scholar
  129. 129.
    Eames TH. A study of tubular and spiral central fields in hysteria. Am J Ophthalmol. 1947;30:610–1.PubMedCrossRefGoogle Scholar
  130. 130.
    Eapen A, Sivaswamy L. Unilateral pupillary dilatation in an 11-year-old girl. Pediatr Neurol. 2014;50:117–8.PubMedCrossRefGoogle Scholar
  131. 131.
    Eapen A, Sivaswamy L, Agarwal R, Thomas R. Management of pediatric migraine in a tertiary care versus community based emergency department: an observational pilot study. Pediatr Neurol. 2014;50:164–70.PubMedCrossRefGoogle Scholar
  132. 132.
    Edgell HG, Kolvin I. Childhood hallucinations. J Child Psychol Psychiatry. 1972;13:279–87.CrossRefGoogle Scholar
  133. 133.
    Egan RA. Ocular motor features of alternating hemiplegia of childhood. J Neuroophthalmol. 2002;22:99–101.PubMedCrossRefGoogle Scholar
  134. 134.
    Ehrt O. Posterior pole ectasia as a rare cause of amblyopia not responsive to therapy. Presented as a poster at the International Strabismological Association, Kyoto, Japan, Dec 1-4; 2014.Google Scholar
  135. 135.
    Ehyai AB, Fenichel GM. The natural history of acute confusional migraine. Arch Neurol. 1978;35:368–9.PubMedCrossRefGoogle Scholar
  136. 136.
    Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010;12:379–89.PubMedCrossRefGoogle Scholar
  137. 137.
    El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr. 2013;167:250–8.PubMedPubMedCentralCrossRefGoogle Scholar
  138. 138.
    Elliot D, Traboulsi EI, Maumenee IH. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol. 1993;115:360–7.CrossRefGoogle Scholar
  139. 139.
    Elser JM, Woody RC. Migraine headache in the infant and young child. Headache. 1990;30:366–8.PubMedCrossRefGoogle Scholar
  140. 140.
    Emery 3rd ES. Acute confusional state in children with migraine. Pediatrics. 1977;60:110–4.Google Scholar
  141. 141.
    Engelsen BA, Tzoulis C, Karlsen B, et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008;131:818–28.PubMedCrossRefGoogle Scholar
  142. 142.
    Epstein LG, Zee PC. Infantile colic and migraine. JAMA. 2013;309:1636–7.PubMedCrossRefGoogle Scholar
  143. 143.
    Erbek SH, Erbek SS, Yilmaz I, et al. Vertigo in childhood: a clinical experience. Int J Pediatr Otorhinolaryngol. 2006;70:1547–54.PubMedCrossRefGoogle Scholar
  144. 144.
    Espinosa-Sanchez JM, Lopez-Excamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:12. doi: 10.3389/fneur.2015.00012.eCollection 2015. Review.PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Evans RW, Digre KB. Light sensitivity in migraineurs. Headache. 2003;43:917–20.PubMedCrossRefGoogle Scholar
  146. 146.
    Fang W, Huang C-C, Lee C-C, Cheng S-Y, Pang C-Y, Wei Y-H. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol. 1993;50:977–80.PubMedCrossRefGoogle Scholar
  147. 147.
    Faria V, Linnman C, Lebel A, Borsook D. Harnessing the placebo effect in pediatric migraine clinic. J Pediatr. 2014;165:659–65.PubMedPubMedCentralCrossRefGoogle Scholar
  148. 148.
    Feinberg WM, Rapcsak SZ. “Peduncular hallucinosis” following paramedian thalamic infarction. Neurology. 1989;39:1535–6.PubMedCrossRefGoogle Scholar
  149. 149.
    Ferreira J, Garcia N, Pedreira L. Topiramate in pediatric and adolescent migraine patients: a retrospective analysis (abstract). Headache. 2002;42:453.Google Scholar
  150. 150.
    Ferrie C, Caraballo R, Covanis A, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol. 2006;48:236–40.PubMedCrossRefGoogle Scholar
  151. 151.
    Fisher CM, Adams RD. Transient global amnesia. Trans Am Neurol Assoc. 1958;83:143–5.Google Scholar
  152. 152.
    Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7:9–17.PubMedGoogle Scholar
  153. 153.
    Fishman GA, Farber M, Patel BS, Derlacki DJ. Visual acuity loss in Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–14.PubMedCrossRefGoogle Scholar
  154. 154.
    Fletcher WA, Imes RK, Goodman D, Hoyt WF. Acute idiopathic blind spot enlargement. A big blind spot syndrome without optic disc edema. Arch Ophthalmol. 1988;106:44–9.PubMedCrossRefGoogle Scholar
  155. 155.
    Forsyth WI, Gillies D, Sills M. Propranolol (“Inderal”) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26:737–41.CrossRefGoogle Scholar
  156. 156.
    Friedman DI. The ophthalmoplegic migraines: a proposed classification. Cephalalgia. 2010;30:646–7.PubMedCrossRefGoogle Scholar
  157. 157.
    Friedman JR, Kosmorsky JS, Burde RM. Stereoacuity in patients with optic nerve disease. Arch Ophthalmol. 1985;103:37–8.PubMedCrossRefGoogle Scholar
  158. 158.
    Frisen L, Hoyt WF, Bird AC, Weale RA. Diagnostic uses of the Pulfrick phenomenon. Lancet. 1973;18:375–6.Google Scholar
  159. 159.
    Frosk P, Mhanni AA, Rafay MF. SCN1A mutation associated with intractable myoclonic epilepsy and migraine headache. J Child Neurol. 2013;28:389–91.PubMedCrossRefGoogle Scholar
  160. 160.
    Fujinami K, Lois N, Davidson AE, et al. A longitudinal study of Stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013;155:1075–88.Google Scholar
  161. 161.
    Fujinami K, Zernant J, Chana RK, et al. Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology. 2015;122:326–34.PubMedCrossRefGoogle Scholar
  162. 162.
    Fusco L, Vigevano F. Alternating hemiplegia of childhood: clinical finding during attacks. In: Anderman F, Aicardi J, Vigevano F, editors. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995. p. 29–41.Google Scholar
  163. 163.
    Gallanti A, Cardin V, Tonelli A, et al. The genetic features of 24 patients affected by familial and sporadic hemiplegic migraine. Neurol Sci. 2011;32S:S141–2.CrossRefGoogle Scholar
  164. 164.
    Gancher ST, Nutt JG. Autosomal dominant episodic ataxia: a heterogenous syndrome. Mov Disord. 1986;1:329–53.CrossRefGoogle Scholar
  165. 165.
    Gardner-Thorpe C, Kocen RS. Subacute sclerosing panencephalitis presenting as transient homonymous hemianopia. J Neurol Neurosurg Psychiatry. 1983;46:186–7.PubMedPubMedCentralCrossRefGoogle Scholar
  166. 166.
    Garralda ME. Hallucinations in children with conduct and emotional disorders. I: the clinical phenomena. Psychol Med. 1984;14:589–96.PubMedCrossRefGoogle Scholar
  167. 167.
    Garralda ME. Hallucinations in children with conduct and emotional disorders. II: the follow-up study. Psychol Med. 1984;14:597–604.PubMedCrossRefGoogle Scholar
  168. 168.
    Gascon GG. Chronic and recurrent headaches in children and adolescents. Pediatr Clin North Am. 1984;31:1027–51.PubMedGoogle Scholar
  169. 169.
    Gascon G, Barlow C. Juvenile migraine presenting as an acute confusional state. Pediatrics. 1970;45:628–35.PubMedGoogle Scholar
  170. 170.
    Gasparini CF, Sutherland HG, Griffith LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics. 2013;14:300–15.PubMedPubMedCentralCrossRefGoogle Scholar
  171. 171.
    Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, I. 3rd ed. St Louis, MO: CV Mosby; 1987. p. 256–8.Google Scholar
  172. 172.
    Gastaut H. A new type of epilepsy: benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr. 1982;13:13–22.PubMedGoogle Scholar
  173. 173.
    Gastaut H. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Dravet CH, Bureau M, Dreiffus FE, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey; 1995. p. 150–70.Google Scholar
  174. 174.
    Gastaut H. Clinical Analysis in the Epilepsies: Electroclinical Correlations. Springfield: Charles C. Thomas; 1954. p. 8–44.Google Scholar
  175. 175.
    Gefland AA, Thomas KC, Goadsby PJ. Before the headache: infant colic as an early life expression of migraine. Neurology. 2012;79:1392–6.CrossRefGoogle Scholar
  176. 176.
    Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol. 1987;21:602–4.PubMedCrossRefGoogle Scholar
  177. 177.
    Gibbs FA, Gibbs EL. Atlas of Electroencephalography, II: Epilepsy. Cambridge, MA: Addison-Wesley Press; 1952. p. 222–4.Google Scholar
  178. 178.
    Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNAIA mutation. Dev Med Child Neurol. 2002;44:490–3.PubMedCrossRefGoogle Scholar
  179. 179.
    Giffen NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60:935–40.CrossRefGoogle Scholar
  180. 180.
    Gittinger Jr JW, Miller NR, Keltner JL, Burde RM. Sugarplum fairies: visual hallucinations. Surv Ophthalmol. 1982;27:42–8.PubMedCrossRefGoogle Scholar
  181. 181.
    Glista GG, Mellinger JF, Rooke ED. Familial hemiplegic migraine. Mayo Clin Proc. 1975;50:307–11.PubMedGoogle Scholar
  182. 182.
    Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules, and therapeutics. Trends Mol Med. 2007;13:39–44.PubMedCrossRefGoogle Scholar
  183. 183.
    Goadsby PJ. Sporadic hemiplegic migraine: stamp collecting or food for thought? Neurology. 2003;60:536–7.PubMedCrossRefGoogle Scholar
  184. 184.
    Goadsby PJ. Stress and migraine: something expected, something unexpected. Neurology. 2014;82:1388–9.PubMedCrossRefGoogle Scholar
  185. 185.
    Goadsby PJ, Duckworth JW. Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol. 1987;253:R270–4.PubMedGoogle Scholar
  186. 186.
    Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat. 1997;190:367–75.PubMedPubMedCentralCrossRefGoogle Scholar
  187. 187.
    Goadsby PJ, Kullmann DK. Another migraine gene. Lancet. 2005;366:345–6.PubMedCrossRefGoogle Scholar
  188. 188.
    Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med. 2002;346:257–70.PubMedCrossRefGoogle Scholar
  189. 189.
    Goadsby PJ, Silberstein SD. Headache. In: Asbury A, Marsden CD, editors. Blue Books in Practical Neurology. New York: Butterworth-Heinemann; 1997.Google Scholar
  190. 190.
    Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation if six cases. Compr Psychiatry. 1989;30:90–8.PubMedCrossRefGoogle Scholar
  191. 191.
    Golden GS. The Alice in Wonderland syndrome in juvenile migraine. Pediatrics. 1979;63:517–9.PubMedGoogle Scholar
  192. 192.
    Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–9.PubMedPubMedCentralCrossRefGoogle Scholar
  193. 193.
    Gonzalez-Cuevas M, Toledo M, Santamarina E, et al. Visual epileptic seizures: signs and symptoms, can clinical implications. Rev Neurol. 2015;60:257–62.PubMedGoogle Scholar
  194. 194.
    Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache. 1991;31:533–6.PubMedCrossRefGoogle Scholar
  195. 195.
    Goodale MA, Milner AD. Sight Unseen: An Exploration of Conscious and Unconscious Vision. Oxford: Oxford University Press; 2005.Google Scholar
  196. 196.
    Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology. 1992;42:545–50.PubMedCrossRefGoogle Scholar
  197. 197.
    Gowers WR. Cases of cerebral tumor illustrating diagnosis and localization. Lancet. 1879;1:363–5.CrossRefGoogle Scholar
  198. 198.
    Graefe A. Über ein einfaches Mittel, Sinulation einseitiger Amaurose zu entdecken, nebst Bemerkungen über die Pupillar-Kontracktion bei Erblindeten. Graefe’s Arch Ophthalmol. 1855;2:266–72.Google Scholar
  199. 199.
    Graether JM. Transient amaurosis in one eye with simultaneous dilation of retinal veins: in association with a congenital anomaly of the optic nerve head. Arch Ophthalmol. 1963;70:342–5.PubMedCrossRefGoogle Scholar
  200. 200.
    Graf WD, Chatrian GE, Glass ST, Knauss TA. Video game-related seizures: a report on 10 patients and a review of the literature (review). Pediatrics. 1994;93:551–6.PubMedGoogle Scholar
  201. 201.
    Grant WM. Toxicology of the Eye. 2nd ed. Springfield, IL: Charles C. Thomas; 1974. p. 55–6.Google Scholar
  202. 202.
    Greenblatt SH. Post-traumatic cerebral blindness: association with migraine and seizure diathesis. JAMA. 1973;225:1073–6.PubMedCrossRefGoogle Scholar
  203. 203.
    Gross C. The many faces of infectious mononucleosis: the spectrum of Epstein-Barr virus infection in children. Pediatr Rev. 1985;7:35–44.CrossRefGoogle Scholar
  204. 204.
    Grüter T, Grüter M. An underestimated handicap: congenital prosopagnosia. Geneva: EUPO course; 2008. p. 51–53, Sept. 5–7.Google Scholar
  205. 205.
    Grüter M, Grüter T, Bell V, et al. Hereditary prosopagnosia: the first case series. Cortex. 2007;43:734–49.CrossRefGoogle Scholar
  206. 206.
    Grüter T, Grüter M, Carbon CC. Neural and genetic foundations of face recognition and prosopagnosia. J Neuropsychol. 2008;2:79–97.PubMedCrossRefGoogle Scholar
  207. 207.
    Guggenheim FG, Smith GR. Somatoform disorders. In: Kaplan BJ, Sadock BJ, editors. Comprehensive Textbook of Psychiatry. 6th ed. Baltimore: Williams and Wilkins; 1995. p. 1251–70.Google Scholar
  208. 208.
    Guilleminault C, editor. Sleep and Its Disorders in Children. New York: Raven Press; 1987. p. 181–3.Google Scholar
  209. 209.
    Guilleminault C. Narcolepsy. In: Chokroverty S, editor. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Boston: Butterworth Heinemann; 1994. p. 241–3.CrossRefGoogle Scholar
  210. 210.
    Haan J, Terwindt GM, Ferrari MD. Genetics of migraine. Adv Headache. 1997;15:43–60.Google Scholar
  211. 211.
    Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology. 1973;23:570–9.PubMedCrossRefGoogle Scholar
  212. 212.
    Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98:4687–92.PubMedPubMedCentralCrossRefGoogle Scholar
  213. 213.
    Hakkarainen J, Quiding H, Stockman O. Mild analgesics as an alternative to ergotamine in migraine: a comparative trial with acetylsalicylic acid, ergotamine tartrate, and dextropropoxyphene compound. J Clin Pharmacol. 1980;20:590–5.PubMedCrossRefGoogle Scholar
  214. 214.
    Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology. 1997;48:103–7.PubMedCrossRefGoogle Scholar
  215. 215.
    Hamed LM, Glaser JS, Gass JDM, Schatz NJ. Protracted enlargement of the blind spot in multiple evanescent white dot syndrome. Arch Ophthalmol. 1989;107:194–8.PubMedCrossRefGoogle Scholar
  216. 216.
    Hanington E. Migraine: a blood disorder? Lancet. 1978;1:501–2.CrossRefGoogle Scholar
  217. 217.
    Hanson RR. Headaches in childhood. Semin Neurol. 1988;8:51–60.PubMedCrossRefGoogle Scholar
  218. 218.
    Harding GF, Wild JM, Robertson KA, et al. Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia. 2000;41:1420–31.PubMedCrossRefGoogle Scholar
  219. 219.
    Harris W. Hemianopsia with special reference to its transient varieties. Brain. 1897;20:308–64.CrossRefGoogle Scholar
  220. 220.
    Hartong DT, Pott J-WR, Kooijman AC. Six patients with bradyopsia (slow vision): clinical features and course of the disease. Ophthalmology. 2007;114:2323–31.PubMedCrossRefGoogle Scholar
  221. 221.
    Hauser RA, Lacey M, Knight R. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45:1078–83.PubMedCrossRefGoogle Scholar
  222. 222.
    Headache Classification Committee of the International Headache Society (IIH). The International Classification of Headache Disorders, 3rd ed (beta version). Cephalalgia. 2013;33:629–808.Google Scholar
  223. 223.
    Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9–160.CrossRefGoogle Scholar
  224. 224.
    Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache. 1989;29:507–9.PubMedCrossRefGoogle Scholar
  225. 225.
    Hewitt DJ, Aurora SK, Dodick DW, et al. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the treatment of migraine. Cephalalgia. 2011;31:712–22.PubMedCrossRefGoogle Scholar
  226. 226.
    Hewitt DJ, Pearlman E, Hämäläinen M, et al. Long-term open-label safety study of Rizatriptan acute treatment in pediatric migraineurs. Headache. 2013;53:104–17.PubMedCrossRefGoogle Scholar
  227. 227.
    Hicks PA, Leavitt JA, Mokris B. Ophthalmic manifestations of vertebral artery dissection: patients seen at the Mayo Clinic from 1976–1992. Ophthalmology. 1994;101:1786–92.PubMedCrossRefGoogle Scholar
  228. 228.
    Highley M, Meller ST, Pinkerton CR. Seizures and cortical dysfunction following high-dose cisplatin administration in children. Med Pediatr Oncol. 1992;20:143–8.PubMedCrossRefGoogle Scholar
  229. 229.
    Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as “retinal migraine” are not migraine. J Neuroophthalmol. 2007;27:3–8.PubMedCrossRefGoogle Scholar
  230. 230.
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.PubMedCrossRefGoogle Scholar
  231. 231.
    Hirai T, Sato M, Kachi S, et al. Similar etiologies of functional visual loss observed in children and adults. Binocul Vis Strabismus Q. 2005;20:218–23.PubMedGoogle Scholar
  232. 232.
    Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9:4–13.PubMedCrossRefGoogle Scholar
  233. 233.
    Ho CS, Shen EY, Liaw SB, Huang FY. Clinical observation and neurological outcomes in “Alice in Wonderland” syndrome. Zhoghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992;33:89–95.Google Scholar
  234. 234.
    Hockaday JM. Basilar migraine in childhood. Dev Med Child Neurol. 1979;21:455–63.PubMedCrossRefGoogle Scholar
  235. 235.
    Holder G, Gale RP, Acheson JF, Robson AG. Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol. 2009;22:3–10.PubMedCrossRefGoogle Scholar
  236. 236.
    Holmes G. Sabill memorial oration on local epilepsy. Lancet. 1927;1:957–62.CrossRefGoogle Scholar
  237. 237.
    Holtzman RN, Goldensohn ES. Sensations of ocular movement in seizures originating in occipital lobe. Neurology. 1977;27:554–6.PubMedCrossRefGoogle Scholar
  238. 238.
    Hoyt CS. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology. 1980;87:245–51.PubMedCrossRefGoogle Scholar
  239. 239.
    Hughes MS, Lessell S. Trazadone-induced palinopsia. Arch Ophthalmol. 1990;108:399–400.PubMedCrossRefGoogle Scholar
  240. 240.
    Hupp SL, Kline LB, Corbett JJ. Visual disturbances of migraine. Surv Ophthalmol. 1989;33:221–36.PubMedCrossRefGoogle Scholar
  241. 241.
    Huppertz H-J, Franck P, Korinthenberg R, Schulze-Bonhage A. Recurrent attacks of fear and visual hallucinations in a child. J Child Neurol. 2002;17:230–3.PubMedCrossRefGoogle Scholar
  242. 242.
    International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24 Suppl 1:1–160.Google Scholar
  243. 243.
    Ip JM, Robaei D, Rochtchina E, Mitchell P. Prevalence of eye disorders in young children with eyestrain complaints. Am J Ophthalmol. 2006;142:495–7.PubMedCrossRefGoogle Scholar
  244. 244.
    Jacobson LK, Dutton GN. Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol. 2000;45:1–13.PubMedCrossRefGoogle Scholar
  245. 245.
    Jäger HR, Giffin NJ, Goadsby PJ. Diffusion- and perfusion-weighted MR imaging and persistent migrainous visual disturbances. Cephalalgia. 2005;25:323–32.PubMedCrossRefGoogle Scholar
  246. 246.
    Jahn K, Langhagen T, Schroeder AS, Heinen F. Vertigo and dizziness in childhood—update on diagnosis and treatment. Neuropediatrics. 2011;42:129–34.PubMedCrossRefGoogle Scholar
  247. 247.
    Jan MM. History of motion sickness is predictive of childhood migraine. J Paediatr Child Health. 1998;34:483–4.PubMedCrossRefGoogle Scholar
  248. 248.
    Jardri R, Bartels-Velthius AA, Debbané M, et al. From phenomenology to neurophysiological understanding of hallucinations in children and adolescents. Schizophr Bull. 2014;40:S221–32.PubMedPubMedCentralCrossRefGoogle Scholar
  249. 249.
    Jayasundera T, Rhoades W, Branham K, Niziol LM, Musch DC, Heckenlively JR. Peripapillary dark choroid ring as a helpful diagnostic sign in advanced Stargardt disease. Am J Ophthalmol. 2010;149:656–60.PubMedCrossRefGoogle Scholar
  250. 250.
    Jorgensen KA, Sorensen P, Freund L. Effective glucocorticosteroids on some coagulation tests. Acta Hematol [Basel]. 1982;68:39–42.Google Scholar
  251. 251.
    Josephson SA, Kirsch HE. Complex visual hallucinations as post-ictal cortical release phenomena. Neurocase. 2006;12:107–10.PubMedCrossRefGoogle Scholar
  252. 252.
    Joutel A, Bousser M-G, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40–5.PubMedCrossRefGoogle Scholar
  253. 253.
    Jürgen TP, Schulte LH, May A. Migraine trait symptoms in migraine with and without aura. Neurology. 2014;82:1413–24.Google Scholar
  254. 254.
    Kabuto T, Takahashi H, Goto-Fukuura Y, et al. A new mutation in the RP1L1 gene in a patient with occult macular dystrophy associated with a depolarizing pattern of focal macular electroretinograms. Mol Vis. 2012;18:1031–9.PubMedPubMedCentralGoogle Scholar
  255. 255.
    Kaiser HJ, Flammer J, Gasser P. Ocular vasospasm in children. Neuro-ophthalmology. 1993;13:263–7.CrossRefGoogle Scholar
  256. 256.
    Kaminer Y, Hrecznyj B. Lysergic acid diethylamide-induced chronic visual disturbances in an adolescent. J Nerv Ment Dis. 1991;179:173–4.PubMedCrossRefGoogle Scholar
  257. 257.
    Kanavakis E, Xaidara A, Papathanasiou-Klontza D, Velentza S, Youroukos S. Alternating hemiplegia of childhood: a syndrome inherited with an autosomal dominant trait. Dev Med Child Neurol. 2003;45:833–6.Google Scholar
  258. 258.
    Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013;339:1092–5.PubMedCrossRefGoogle Scholar
  259. 259.
    Karlson CW, Litzenburg CC, Sampilo ML, et al. Relationship between daily mood and migraine in children. Headache. 2013;53:1624–34.PubMedPubMedCentralCrossRefGoogle Scholar
  260. 260.
    Kasteijn-Nolst-Trenité D, Rubboli G, Hirsch E, et al. Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia. 2012;53:16–24.CrossRefGoogle Scholar
  261. 261.
    Kathol RG, Cox TA, Corbett JJ, Thompson HS, Clancy J. Functional visual loss. I: a true psychiatric disorder? Psychol Med. 1983;13:307–14.PubMedCrossRefGoogle Scholar
  262. 262.
    Kathol RG, Cox TA, Corbett JJ, Thompson HS, Clancy J. Functional visual loss. II: psychiatric aspects in 42 patients followed for 4 years. Psychol Med. 1983;13:315–24.PubMedCrossRefGoogle Scholar
  263. 263.
    Kathol RG, Cox TA, Corbett JJ, Thompson HS. Functional visual loss: follow-up of 42 cases. Arch Ophthalmol. 1983;101:729–35.PubMedCrossRefGoogle Scholar
  264. 264.
    Katz B, Hoyt WF. Intrapapillary and peripapillary hemorrhage in young patients with uncomplicated posterior vitreous detachment: signs of vitreopapillary traction. Ophthalmology. 1995;102:349–54.PubMedCrossRefGoogle Scholar
  265. 265.
    Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993;629:95–102.PubMedCrossRefGoogle Scholar
  266. 266.
    Kaul S, Uparkar M, Sivaraman A, et al. Isolated foveal hypoplasia with good visual acuity and absence of nystagmus. JAAPOS. 2008, in press.Google Scholar
  267. 267.
    Kinast M, Lueders H, Rothner AD, Erenberg G. Benign focal epileptiform discharges in childhood migraine (BFEDC). Neurology. 1982;32:1309–12.PubMedCrossRefGoogle Scholar
  268. 268.
    Kinetz E. Is hysteria real? Brain images say yes. New York Times; Sept. 26, 2006.Google Scholar
  269. 269.
    King RA. Common ocular signs and symptoms in children. Pediatr Clin North Am. 1993;40:753–66.PubMedGoogle Scholar
  270. 270.
    Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol. 1979;97:1680–6.PubMedCrossRefGoogle Scholar
  271. 271.
    Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache. 1980;20:253–7.PubMedCrossRefGoogle Scholar
  272. 272.
    Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 1992;12:169–71.PubMedCrossRefGoogle Scholar
  273. 273.
    Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience. 2001;106:793–800.PubMedCrossRefGoogle Scholar
  274. 274.
    Kondo M, Ueno S, Piao C-H, Ito Y, Teresaki H, Miyake Y. Occult macular dystrophy in an 11 year old boy. Br J Ophthalmol. 2004;88:1602–3.PubMedPubMedCentralCrossRefGoogle Scholar
  275. 275.
    Kooi KA. Episodic blindness as a late effect of head trauma: electrophysiological study of three cases. Neurology. 1970;20:569–73.PubMedCrossRefGoogle Scholar
  276. 276.
    Kosnik E, Paulson GW, Laguna JF. Postictal blindness. Neurology. 1976;26:248–50.PubMedCrossRefGoogle Scholar
  277. 277.
    Koutroumanidis M. Panayiotopoulos syndrome. Br Med J. 2002;324:1228–9.CrossRefGoogle Scholar
  278. 278.
    Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427–34.PubMedCrossRefGoogle Scholar
  279. 279.
    Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–7.PubMedCrossRefGoogle Scholar
  280. 280.
    Kupersmith MJ. Neurovascular Neuro-ophthalmology. New York: Springer; 1993. p. 452–3.CrossRefGoogle Scholar
  281. 281.
    Kupersmith MJ, Warren FA, Hass WK. The nonbenign aspects of migraine. Neuro-ophthalmology. 1987;7:1–10.Google Scholar
  282. 282.
    Laffi GL, Safran AB. Persistent visual hallucinations following hashish consumption. Br J Ophthalmol. 1993;77:601–2.PubMedPubMedCentralCrossRefGoogle Scholar
  283. 283.
    Lagae L. What’s new in: “genetics in childhood epilepsy”. Eur J Pediatr. 2008;167:715–22.PubMedCrossRefGoogle Scholar
  284. 284.
    Lai TYY, Chan W-M, Lai RYK, Ngai JWS, Li H, Lam DSC. The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol. 2007;52:61–96.PubMedCrossRefGoogle Scholar
  285. 285.
    Lambertus S, van Huet RAC, Bax NM, et al. Early-onset Stargardt disease: phenotypic and genotypic characteristics. Ophthalmology. 2015;122:335–44.PubMedCrossRefGoogle Scholar
  286. 286.
    Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain. 1976;99:719–34.PubMedCrossRefGoogle Scholar
  287. 287.
    Lanska JR, Lanska DJ. Alice in Wonderland syndrome: somesthetic vs visual perceptual disturbance. Neurology. 2013;80:1262–4.PubMedCrossRefGoogle Scholar
  288. 288.
    Lanska DJ, Lanska MJ. Visual “release” hallucinations in juvenile neuronal ceroid-lipofuscinosis. Pediatr Neurol. 1993;9:316–7.PubMedCrossRefGoogle Scholar
  289. 289.
    Lanska DJ, Lanska MJ, Mendez MF. Brainstem auditory hallucinosis. Neurology. 1987;37:1685.PubMedCrossRefGoogle Scholar
  290. 290.
    Lapkin ML, Golden GS. Basilar artery migraine: a review of 30 cases. Am J Dis Child. 1978;132:278–81.PubMedCrossRefGoogle Scholar
  291. 291.
    Lashley KS. Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiatry. 1941;46:331–9.CrossRefGoogle Scholar
  292. 292.
    Lauritzen M. Cortical spreading depression as a putative migraine mechanism. Trends Neurosci. 1987;10:8–13.CrossRefGoogle Scholar
  293. 293.
    Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain. 1994;117:199–210.PubMedCrossRefGoogle Scholar
  294. 294.
    Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by xenon 133 inhalation and emission tomography. Brain. 1984;107:447–61.PubMedCrossRefGoogle Scholar
  295. 295.
    La Vega-Talbot M, Duchowny M, Jayakar P. Orbitofrontal seizures presenting with ictal visual hallucinations and interictal psychosis. Pediatr Neurol. 2006;35:78–81.PubMedCrossRefGoogle Scholar
  296. 296.
    Lawden MC, Eke T, Degg C, Harding GFA, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry. 1999;67:716–22.PubMedPubMedCentralCrossRefGoogle Scholar
  297. 297.
    Lee M, Brace J, McKinney A, Santa-Cruz K. Progressive visual loss in a man with leukemia. Presented at the Frank B Walsh Society Meeting, Lake Tahoe, Nevada on February 22, 2008.Google Scholar
  298. 298.
    Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–52.PubMedCrossRefGoogle Scholar
  299. 299.
    Lehnen N, Langhagen T, Heinen F, Huppert D, Brandt T, Jahn K. Vestibular paroxysmia in children: a treatable cause of short vertigo attacks. Dev Med Child Neurol. 2014, in press.Google Scholar
  300. 300.
    Leo AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359–90.Google Scholar
  301. 301.
    Lepore FE. Dr. Airy’s “morbid affection of the eyesight”: lessons from teichopsia circa 1870. J Neuroophthalmol. 2014;34:311–4.PubMedCrossRefGoogle Scholar
  302. 302.
    Lepore FE. Spontaneous visual phenomenon with visual loss: 104 patients with lesions of the retinal and neural afferent pathways. Neurology. 1990;40:444–7.PubMedCrossRefGoogle Scholar
  303. 303.
    Lepore FE. Uhthoff’s symptoms in disorders of the anterior visual pathways. Neurology. 1994;44:1036–8.PubMedCrossRefGoogle Scholar
  304. 304.
    Lessell S. Higher disorders of visual function: positive phenomenon. In: Glaser JS, Smith JL, editors. Neuro-ophthalmology, vol. VIII. St. Louis: C.V. Mosby; 1975. p. 27–44.Google Scholar
  305. 305.
    Lessell S. Nonorganic visual loss: what’s in a name. Am J Ophthalmol. 2011;151:569–71.PubMedCrossRefGoogle Scholar
  306. 306.
    Lessell S, Cohen MM. Phosphenes induced by sound. Neurology. 1979;38:1524–6.CrossRefGoogle Scholar
  307. 307.
    Levi L, Miller NR. Visual illusions associated with previous drug allergy. J Clin Neuroophthalmol. 1990;10:103–10.PubMedGoogle Scholar
  308. 308.
    Lewis D, Ashwal S, Dahl G, et al. American Academy of Neurology practice parameter: evaluation of children and adolescents with recurrent headaches. Neurology. 2002;59:490–8.Google Scholar
  309. 309.
    Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215–24.PubMedCrossRefGoogle Scholar
  310. 310.
    Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache. 2004;44:230–7.PubMedCrossRefGoogle Scholar
  311. 311.
    Lewis DW, Kellstein D, Dahl G, et al. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780–6.PubMedCrossRefGoogle Scholar
  312. 312.
    Lewis RA, Vijayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology. 1989;96:321–6.PubMedCrossRefGoogle Scholar
  313. 313.
    Lhermitte J. Syndrome de la calotte du pedoncule cerebral. Les troubles psycho-sensoriels dans les lesions du mesodphale. Rev Neurol (Paris). 1922;38:1359–65.Google Scholar
  314. 314.
    Liaw SB, Shen EY. Alice in Wonderland syndrome as a presenting symptom of EBV infection. Pediatr Neurol. 1991;7:464–6.PubMedCrossRefGoogle Scholar
  315. 315.
    Lim SA, Siatkowski RM, Farris BK. Functional visual loss in adults and children: patient characteristics, management, and outcomes. Ophthalmology. 2005;112:1821–8.PubMedCrossRefGoogle Scholar
  316. 316.
    Limmroth V, May A, Auerbach P, Wosnitza G, Eppe T, Diener HC. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996;138:60–5.PubMedCrossRefGoogle Scholar
  317. 317.
    Lippman CW. Certain hallucinations peculiar to migraine. J Nerv Ment Dis. 1952;116:346–51.PubMedCrossRefGoogle Scholar
  318. 318.
    Lipton RB, Buse DC, Hall CB, et al. Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis. Neurology. 2014;82:1395–401.PubMedPubMedCentralCrossRefGoogle Scholar
  319. 319.
    Lipton RB, Ottman R, Ehrenberg BL, Hauser WA. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994;44 Suppl 7:S28–S32.PubMedGoogle Scholar
  320. 320.
    Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA. 2004;28:493–4.CrossRefGoogle Scholar
  321. 321.
    Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–57.PubMedCrossRefGoogle Scholar
  322. 322.
    Little RD, Goldstein JL. Alexia without agraphia in a child with acute disseminated encephalomyelitis. Neurology. 2006;67:725.PubMedCrossRefGoogle Scholar
  323. 323.
    Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology. 1995;45:664–8.PubMedCrossRefGoogle Scholar
  324. 324.
    Loewenstein JI. Visual hallucinations in patients with choroidal neovascularization. JAMA. 1994;272:243.PubMedCrossRefGoogle Scholar
  325. 325.
    Lorentzen SE. Drusen of the optic disk. A clinical and genetic study. Dan Med Bull. 1967;14:293–8.Google Scholar
  326. 326.
    Losada-Del Pozo R, Cantarín-Extremera V, García-Peñas JJ, et al. Characteristics and evolution of patients with Alice in Wonderland syndrome [article in Spanish]. Rev Neurol. 2011;53:641–8.PubMedGoogle Scholar
  327. 327.
    Lowery RS, Atkinson D, Lambert SR. Cryptic cerebral impairment in children. Br J Ophthalmol. 2006;90:960–3.PubMedPubMedCentralCrossRefGoogle Scholar
  328. 328.
    Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50:109–15.PubMedCrossRefGoogle Scholar
  329. 329.
    Ludwig BI, Marsan CA. Clinical ictal patterns in epileptic patients with occipital electroencephalographic foci. Neurology. 1975;25:463–71.PubMedCrossRefGoogle Scholar
  330. 330.
    MacDonald JT. Childhood migraine: differential diagnosis and treatment. Postgrad Med. 1986;80:301–4, 306.PubMedCrossRefGoogle Scholar
  331. 331.
    MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34:581–2.PubMedCrossRefGoogle Scholar
  332. 332.
    Mack KJ. Headaches in children. In: Aicardi J, editor. Diseases of the Nervous System in Childhood. 4th ed. Wiley Press; 2015, in press.Google Scholar
  333. 333.
    Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin: asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ. 1998;316:233.PubMedPubMedCentralGoogle Scholar
  334. 334.
    Macnab AJ, Bennett M. Refrigerator blindness: selective loss of visual acuity in association with a common foraging behavior. CMAJ. 2005;173:1494–5.PubMedPubMedCentralGoogle Scholar
  335. 335.
    Magis D. Neuromodulation in migraine. State of the art and perspectives. Expert Rev Med Devices. 2015; epub ahead of print.Google Scholar
  336. 336.
    Maitland CG. Ocular motility in childhood migraine. Presented at the North American Neuro-Ophthalmological Society Meeting, Rancho Bernardo, CA; February 23–27, 1992.Google Scholar
  337. 337.
    Maleki N, Becerra L, Upadhyay J, Burstein R, Borsook D. Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: implications for photophobia. Hum Brain Mapp. 2012;33:75–88.PubMedCrossRefGoogle Scholar
  338. 338.
    Manford M, Andermann F. Complex visual hallucinations: clinical and neurobiological insights. Brain. 1998;121:1819–40.PubMedCrossRefGoogle Scholar
  339. 339.
    Mäntyjärvi MI. The amblyopic schoolgirl syndrome. J Pediatr Ophthalmol Strabismus. 1981;18:30–3.PubMedGoogle Scholar
  340. 340.
    Marini C, Conti V, Mei D, et al. PRRT mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology. 2012;79:2109–14.PubMedPubMedCentralCrossRefGoogle Scholar
  341. 341.
    Mark AS, Casselman J, Brown D, et al. Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MRI images. AJNR Am J Neuroradiol. 1998;19:1887–91.PubMedGoogle Scholar
  342. 342.
    Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia. 1988;8:83–91.PubMedCrossRefGoogle Scholar
  343. 343.
    Marra TR, Shah M, Mikus MA. Transient cortical blindness due to hypertensive encephalopathy. Magnetic resonance imaging correlation. J Clin Neuroophthalmol. 1993;13:35–7.PubMedCrossRefGoogle Scholar
  344. 344.
    Martinovic Z. Panayiotopoulos syndrome. Lancet. 2001;358:69.PubMedCrossRefGoogle Scholar
  345. 345.
    Martins-Ferreira H, de Castro GO. Light-scattering changes accompanying spreading depression in isolated retina. J Neurophysiol. 1966;29:715–26.PubMedGoogle Scholar
  346. 346.
    Martins-Ferreira H, Nedergaard M, Nicholson C. Perspectives on spreading depression. Brain Res Rev. 2000;32:215–34.PubMedCrossRefGoogle Scholar
  347. 347.
    Martyn LJ. Discussion of Catalano et al. Functional visual loss in children. Ophthalmology. 1986;93:390.Google Scholar
  348. 348.
    Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital sitmulators: a PET study. Brain. 2004;127:220–30.PubMedCrossRefGoogle Scholar
  349. 349.
    Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology. 1991;41:1043–6.PubMedCrossRefGoogle Scholar
  350. 350.
    Matthews GP, Sandberg MA, Berson EL. Foveal cone electroretinograms in patients with central visual loss of unexplained etiology. Arch Ophthalmol. 1992;110:1568–70.PubMedCrossRefGoogle Scholar
  351. 351.
    McAbee GN, Morse AM, Assadi M. Pediatric aspects of headache classification in the International Classification of Headache Disorders-3 (ICHD-3 beta version). Curr Pain Headache Rep. 2016;20:1–7.Google Scholar
  352. 352.
    McBain VA, Townend J, Lois N. Progression of retinal pigment epithelial atrophy in Stargardt disease. Am J Ophthalmol. 2012;154:146–54.PubMedCrossRefGoogle Scholar
  353. 353.
    McKendrick AM, Badcock DR. Decreased visual field sensitivity measured 1 day, then 1 week, after migraine. Invest Ophthalmol Vis Sci. 2004;45:1061–70.PubMedCrossRefGoogle Scholar
  354. 354.
    McKillop E, Dutton GN. Impairment of vision in children due to damage to the brain: a practical approach. Br Ir Orthopt J. 2008;5:8–14.Google Scholar
  355. 355.
    Meldrum BS, Brierly JB. Prolonged epileptic seizures in primates: ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973;28:10–7.PubMedCrossRefGoogle Scholar
  356. 356.
    Mewasingh LD, Kornreich C, Christiaens F, Christophe C, Dan B. Pediatric phantom vision (Charles Bonnet) syndrome. Pediatr Neurol. 2002;26:143–5.PubMedCrossRefGoogle Scholar
  357. 357.
    Michaelides M, Holder GE, Bradshaw K, Hunt DM, Mollon JD, Moore AT. Oligocone trichromacy: a rare and unusual cone dysfunction syndrome. Br J Ophthalmol. 2004;88:497–500.PubMedPubMedCentralCrossRefGoogle Scholar
  358. 358.
    Mierzwiński J, Polak M, Dalke K, Burduk P, Kaźmierczak H, Modrzyński M. Benign paroxysmal vertigo of childhood. Otolaryngol Pol. 2007;61:307–10.PubMedCrossRefGoogle Scholar
  359. 359.
    Mikati MA, Maguire H, Barlow CF, et al. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy: chromosomal studies; and physiologic investigations. Neurology. 1992;42:2251–7.PubMedCrossRefGoogle Scholar
  360. 360.
    Miller BW. A review of practical tests for ocular malingering and hysteria. Surv Ophthalmol. 1973;17:241–6.PubMedGoogle Scholar
  361. 361.
    Miller NR. Walsh and Hoyt’s Clinical Neuro-ophthalmology, vol. III. 4th ed. Baltimore: Williams and Wilkins; 1995. p. 1398.Google Scholar
  362. 362.
    Miller SP, Sanchez-Avalos J, Stefanski T, Zuckerman L. Coagulation disorders in cancer I: clinical and laboratory studies. Cancer. 1967;20:1452–65.PubMedCrossRefGoogle Scholar
  363. 363.
    Miyake Y, Horiguchi M, Tomita N, et al. Occult macular dystrophy. Am J Ophthalmol. 1996;122:644–53.PubMedCrossRefGoogle Scholar
  364. 364.
    Miyake Y, Ichikawa K, Shiose Y, Kawase Y. Hereditary macular dystrophy without visible fundus abnormality. Am J Ophthalmol. 1989;1108:292–9.CrossRefGoogle Scholar
  365. 365.
    Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ihara I, Yamagata S. Study of the posterior circulation in moyamoya disease. Part 2: visual disturbances and surgical treatment. J Neurosurg. 1986;65:454–60.PubMedCrossRefGoogle Scholar
  366. 366.
    Monteiro JM, Rosas MJ, Correia AP, Vaz AR. Migraine and intracranial vascular malformations. Headache. 1993;33:563–5.PubMedCrossRefGoogle Scholar
  367. 367.
    Morelli N, Rota E. Migraine and patient foramen ovale: barking up the wrong tree? Front Neurol. 2014;5:1–2.CrossRefGoogle Scholar
  368. 368.
    Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia. 1992;12:238–43.PubMedCrossRefGoogle Scholar
  369. 369.
    Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, vahlquist and IHS criteria. Dev Med Child Neurol. 1992;34:1096–101.Google Scholar
  370. 370.
    Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–54.PubMedCrossRefGoogle Scholar
  371. 371.
    Munk MR, Jampol LR, Cunha Souza E, et al. New associations of classic acute macular neuroretinopathy. Br J Ophthalmol. 2015, in press.Google Scholar
  372. 372.
    Nadvi SS, van Dellen JR. Transient peduncular hallucinations secondary to brain stem compression by a medulloblastoma. Surg Neurol. 1994;41:250–2.PubMedCrossRefGoogle Scholar
  373. 373.
    Nagendran K, Prior PF, Rossiter MA. Benign occipital epilepsy of childhood: a family study. J R Soc Med. 1989;82:684–5.PubMedPubMedCentralGoogle Scholar
  374. 374.
    Natowicz M, Kelley RI. Mendelian etiologies of stroke. Ann Neurol. 1987;22:175–92.PubMedCrossRefGoogle Scholar
  375. 375.
    Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia. 2004;24:83–91.PubMedCrossRefGoogle Scholar
  376. 376.
    Newmark ME. Visual hallucinations. JAMA. 1987;257:82. Letter.CrossRefGoogle Scholar
  377. 377.
    Ney JJ, Volpe NJ, Liu GT. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009;116:1808–13.PubMedCrossRefGoogle Scholar
  378. 378.
    Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusion. Semin Neurol. 2000;20:111–21.PubMedCrossRefGoogle Scholar
  379. 379.
    Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Nat Neurosci. 2010;13:239–45.PubMedPubMedCentralCrossRefGoogle Scholar
  380. 380.
    Nyhold DR, Dawkins JL, Brimage PJ, Goadsby PJ, Nicholson GA, Griffiths LR. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet. 1998;7:459–63.CrossRefGoogle Scholar
  381. 381.
    O’Connor PJ, Tredici TJ. Acephalgic migraine: fifteen years experience. Ophthalmology. 1981;88:999–1003.PubMedCrossRefGoogle Scholar
  382. 382.
    O’Hara MA, Anderson RT, Brown D. MR imaging in ophthalmoplegic migraine of children. Presented as a poster at the American Association of Pediatric Ophthalmology and Strabismus, Orlando, FL; April 5–9, 1995.Google Scholar
  383. 383.
    O’Hare AE, Dutton GN, Green D, Coull R. Evolution of a form of pure alexia without agraphia in a child sustaining occipital lobe infarction at 21/2 years. Dev Med Child Neurol. 1998;40:417–20.PubMedGoogle Scholar
  384. 384.
    Okubo Y, Matsuura M, Asai T, et al. Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences. Epilepsia. 1994;35:832–41.PubMedCrossRefGoogle Scholar
  385. 385.
    Olbrich H, Engelmeier MP, Pauleikhoff D, Waubke T. Visual hallucinations in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 1987;225:217–20.PubMedCrossRefGoogle Scholar
  386. 386.
    Olesen J. Migraine and regional cerebral blood flow. Trends Neurosci. 1985;8:318–21.CrossRefGoogle Scholar
  387. 387.
    Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344–52.PubMedCrossRefGoogle Scholar
  388. 388.
    Oliver TA, Hoehn ME, Boop F, Ellison DW. Pituitary adenoma causing visual disturbances in a 6-year-old girl. J AAPOS. 2011;15:495–8.PubMedCrossRefGoogle Scholar
  389. 389.
    Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593–7.PubMedGoogle Scholar
  390. 390.
    Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543–52.PubMedCrossRefGoogle Scholar
  391. 391.
    Osako M, Harasawa K, Suzuki H, Usui M, Hoshika A. The characteristics of static visual fields in children with psychogenic visual disturbances. Jpn J Ophthalmol. 2000;44:516–9.PubMedCrossRefGoogle Scholar
  392. 392.
    O’Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol. 1992;76:660–2.PubMedPubMedCentralCrossRefGoogle Scholar
  393. 393.
    Ota I, Kuroshima K, Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol 2013;131:1481–82. Accessed 13 Nov 2014.
  394. 394.
    Pacheva IH, Ivanov IS. Migraine variants: occurrence in pediatric neurology practice. Clin Neurol Neurosurg. 2013;115:1775–83.PubMedCrossRefGoogle Scholar
  395. 395.
    Panayiotopoulos CP. Benign childhood epilepsy with occipital paroxysms: a 15-year prospective clinical and electroencephalographic study. Ann Neurol. 1989;26:51–6.PubMedCrossRefGoogle Scholar
  396. 396.
    Panayiotopoulos CP. Difficulties in differentiating migraine in epilepsy based on clinical and EEG findings. In: Andermann F, Lugaressi E, editors. Migraine in Epilepsy. Boston: Butterworth; 1987.Google Scholar
  397. 397.
    Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry. 1994;57:1371–4.PubMedPubMedCentralCrossRefGoogle Scholar
  398. 398.
    Panayiotopoulos CP. The birth and evolution of the concept of Panayiotopoulos syndrome. Epilepsia. 2007;48:1041–3.PubMedCrossRefGoogle Scholar
  399. 399.
    Papetti L, Nicita F, Parisi P, Spalice A, Villa MP, Kasteleijn-Nolst Trenité DG. “Headache and Epilepsy”—how are they connected? Epilepsy Behav. 2013;26:386–93.PubMedCrossRefGoogle Scholar
  400. 400.
    Paquier PF, De Smet HJ, Mariën P, Poznanski N, Van Bogaert P. Acquired alexia without agraphia syndrome in childhood. J Child Neurol. 2006;21:324–30.PubMedCrossRefGoogle Scholar
  401. 401.
    Parisi P, Pagani J, Galiffa S, Villa MP. Migrainous vertigo unresponsive to antimigraine therapy in a child with “asymptomatic” cerebellar lesion: casual or causal association? Cephalalgia. 2005;25:831–5.PubMedCrossRefGoogle Scholar
  402. 402.
    Parisi P, Villa MP, Pelliccia A, Rollo VC, Chiarelli F, Verrotti A. Panayiotopoulos syndrome: diagnosis and management. Neurol Sci. 2007;28:72–9.PubMedCrossRefGoogle Scholar
  403. 403.
    Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481–8.PubMedCrossRefGoogle Scholar
  404. 404.
    Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia. 1983;3:129–34.PubMedCrossRefGoogle Scholar
  405. 405.
    Penfield W, Erickson TC. Epilepsy and Cerebral Localization. Springfield: Charles C. Thomas; 1941. p. 101–3.Google Scholar
  406. 406.
    Penfield W, Kristiansen K. Seizure Patterns. Epileptic Seizure Pattern. Springfield: Charles C. Thomas; 1951. p. 16–84.Google Scholar
  407. 407.
    Penfield W, Parot P. The brain’s record of auditory and visual experience. Brain. 1963;86:595–696.PubMedCrossRefGoogle Scholar
  408. 408.
    Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44:53–64.PubMedCrossRefGoogle Scholar
  409. 409.
    Petzold A, Islam N, Plant GT. Video reconstruction of vasospastic transient monocular blindness. N Engl J Med. 2003;348:1609–10.PubMedCrossRefGoogle Scholar
  410. 410.
    Pfaender M, D’Souza WJ, Trost N, Litewka L, Paine M, Cook M. Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and celiac disease: a case series. J Neurol Neurosurg Psychiatry. 2004;75:1623–5.PubMedPubMedCentralCrossRefGoogle Scholar
  411. 411.
    Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365–91.PubMedCrossRefGoogle Scholar
  412. 412.
    Pochedly C, Miller SP, Mehta A. “Hypercoagulable state” in children with acute leukemia or disseminated solid tumors. Oncology. 1973;28:517–22.PubMedCrossRefGoogle Scholar
  413. 413.
    Ponjavic V, Andréasson S. Multifocal ERG and full-field ERG, in patients on long-term vigabatrin medication. Doc Ophthalmol. 2001;102:63–72.PubMedCrossRefGoogle Scholar
  414. 414.
    Porciatti V, Bonanni P, Fiorentini A, Guerrini R. Lack of cortical contrast gain in human photosensitive epilepsy. Nat Neurosci. 2000;3:259–63.PubMedCrossRefGoogle Scholar
  415. 415.
    Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310:2622–30.PubMedPubMedCentralCrossRefGoogle Scholar
  416. 416.
    Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506–10.PubMedCrossRefGoogle Scholar
  417. 417.
    Presad S, Boes AD, Leone AP, Caviness VS, Fox MD. Peduncular hallucinosis: a lesion-based network analysis. Presented at the North American Neuro-Ophthalmology Society meeting, March 4, 2014, Rio Grande, Puerto Rico.Google Scholar
  418. 418.
    Priest JR, Ramsay NK, Bennett AK, Krivit W, Edson JR. The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr. 1982;100:990–5.PubMedCrossRefGoogle Scholar
  419. 419.
    Priest JR, Ramsay NK, Latchaw RE, et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer. 1980;46:1548–54.PubMedCrossRefGoogle Scholar
  420. 420.
    Pui C-H, Jackson CW, Chesney C, et al. Sequential changes in platelet function in coagulation in leukemic children treated with L-asparaginase prednisone of vincristine. J Clin Oncol. 1983;1:380–5.PubMedGoogle Scholar
  421. 421.
    Purvin V, Selky AK. Palinopsia following LSD ingestion. Presented as a poster at the North American Neuro-ophthalmology Society Meeting. Tucson, AZ; Feb 19–23, 1995.Google Scholar
  422. 422.
    Rabinowicz IM. Amblyopia. In: Harley RD, editor. Pediatric Ophthalmology, vol. I. 2nd ed. Philadelphia: WB Saunders; 1983. p. 293–348.Google Scholar
  423. 423.
    Rada RT, Krill AE, Meyer GG, Armstrong D. Visual conversion reaction in children. II. Follow-up. Psychosomatics. 1973;14:271–6.PubMedCrossRefGoogle Scholar
  424. 424.
    Rada RT, Meyer GG, Kellner R. Visual conversion reaction in children and adults. J Nerv Ment Dis. 1978;166:580–7.PubMedCrossRefGoogle Scholar
  425. 425.
    Rafay MF, Armstrong D, deVeber G, Domi T, Chan A, MacGregor DL. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J Child Neurol. 2006;21:8–16.PubMedCrossRefGoogle Scholar
  426. 426.
    Ramadan NM, Tietjen GE, Levine SR, Welch KM. Scintillating scotomata associated with internal carotid artery dissection: report of three cases. Neurology. 1991;41:1084–7.PubMedCrossRefGoogle Scholar
  427. 427.
    Ramsay NK, Coccia PF, Krivit W, Nesbit ME, Edson JR. The effect of L-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia. Cancer. 1977;40:1398–401.PubMedCrossRefGoogle Scholar
  428. 428.
    Raskin NH, Schwartz RK. Icepick-like pain. Neurology. 1980;30:203–5.PubMedCrossRefGoogle Scholar
  429. 429.
    Riedel KG, Zwaan J, Kenyon KR, Kolodny EH, Hanninen L, Albert DM. Ocular abnormalities in mucolipidosis IV. Am J Ophthalmol. 1985;99(2):125–36.PubMedCrossRefGoogle Scholar
  430. 430.
    Rho JM, Chugani HT. Alternating hemiplegia of childhood: insights into its pathophysiology. J Child Neurol. 1998;13:39–45.PubMedCrossRefGoogle Scholar
  431. 431.
    Riant F, Ducros A, Ploton C, Barbance C, Depienne C, Tournier-Lasserve E. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology. 2010;75:967–72.PubMedCrossRefGoogle Scholar
  432. 432.
    Riaz G, Selhorst JB, Hennessey JJ. Meningeal lesions mimicking migraine. Neuro-Ophthalmology. 1991;11:41–8.CrossRefGoogle Scholar
  433. 433.
    Riela AR, Roach ES. Etiology of stroke in children. J Child Neurol. 1993;8:201–20.PubMedCrossRefGoogle Scholar
  434. 434.
    Rinalduzzi S, Valeriani M, Vigevano F. Brainstem dysfunction in alternating hemiplegia of childhood: a neurophysiologic study. Cephalalgia. 2006;26:511–9.PubMedCrossRefGoogle Scholar
  435. 435.
    Rippe DJ, Edwards MK, Schrodt JF, Bognanno JR, D'Amour PG, Boyko OB. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. J Comput Assist Tomogr. 1988;12:1078–81.PubMedCrossRefGoogle Scholar
  436. 436.
    Robertson Jr WC, Schnitzier ER. Ophthalmoplegic migraine in infancy. Pediatrics. 1978;61:886–8.PubMedGoogle Scholar
  437. 437.
    Rolak AL, Baram TZ. Visual hallucinations: more diagnosis. JAMA. 1987;257:2036. Letter.Google Scholar
  438. 438.
    Romanello S, Spiri D, Marcuzzi E, et al. Association between childhood migraine and history of infantile colic. JAMA. 2013;309:1607–12.PubMedCrossRefGoogle Scholar
  439. 439.
    Rosewich H, Ohlenbusch A, Huppke P, et al. The expanding clinical and genetic spectrum of ATP1A3-related disorders. Neurology. 2014;82:945–55.PubMedCrossRefGoogle Scholar
  440. 440.
    Rossi LN, Penzien JM, Deonna T, Goutières F, Vassella F. Does migraine-related stroke occur in childhood? Dev Med Child Neurol. 1990;32:1016–21.PubMedCrossRefGoogle Scholar
  441. 441.
    Rossi LN, Vassella F. Headache in children with brain tumors. Childs Nerv Syst. 1989;5:307–9.PubMedCrossRefGoogle Scholar
  442. 442.
    Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110(6):1151–8.PubMedCrossRefGoogle Scholar
  443. 443.
    Rothner AD, Pirikh S. Migraine variants or episodic syndromes that may be associated with migraine and other unusual pediatric headache syndromes. Headache. 2016;56:206–14.Google Scholar
  444. 444.
    Rotstein M, Doran J, Yang H, Ullner PM, Engelstad K, De Vivo DC. Glut1 deficiency and alternating hemiplegia of childhood. Neurology. 2009;73:2042–4.PubMedPubMedCentralCrossRefGoogle Scholar
  445. 445.
    Rummelt V, Folberg R, Ionasescu V, Yi H, Moore KC. Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology. 1993;100:1757–66.PubMedCrossRefGoogle Scholar
  446. 446.
    Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia. 1996;16:305–9.PubMedCrossRefGoogle Scholar
  447. 447.
    Russell WR, Whitty CWM. Studies in traumatic epilepsy. 3: visual fits. J Neurol Neurosurg Psychiatry. 1955;18:79–96.PubMedPubMedCentralCrossRefGoogle Scholar
  448. 448.
    Rüther K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M. Electrophysiologic evaluation of patients with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol. 1998;116:817–9.Google Scholar
  449. 449.
    Sadeh M, Goldhammer Y, Kuritsky A. Postictal blindness in adults. J Neurol Neurosurg Psychiatry. 1983;46:566–9.PubMedPubMedCentralCrossRefGoogle Scholar
  450. 450.
    Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984;16:489–94.PubMedCrossRefGoogle Scholar
  451. 451.
    Saidkasimova S, Bennett DM, Butler S, Dutton GN. Cognitive visual impairment with good visual acuity in children with posterior periventricular white matter injury. A series of 7 cases. J AAPOS. 2007;11:426–30.PubMedCrossRefGoogle Scholar
  452. 452.
    Salanova V, Andermann F, Olivier A, Rasmussen T, Quesney LF. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Brain. 1992;115:1655–80.PubMedCrossRefGoogle Scholar
  453. 453.
    Sánchez-Albisua I-S, Schöning M, Jurkat-Rott K, Lerch H. Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine. Pediatr Neurol. 2013;49:286–8.PubMedCrossRefGoogle Scholar
  454. 454.
    Sanguineti B, Crovato F, De Marchi R, Desirello G. “Alice in Wonderland” syndrome in a patient with infectious mononucleosis. J Infect Dis. 1983;147:782.PubMedCrossRefGoogle Scholar
  455. 455.
    Sanner G, Bergström B. Benign paroxysmal torticollis in infancy. Acta Paediatr Scand. 1979;68:219–23.PubMedCrossRefGoogle Scholar
  456. 456.
    Santhouse AM, Howard RJ, Ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000;123:2055–64.PubMedCrossRefGoogle Scholar
  457. 457.
    Santos CH, Almeida IL, Gomes MD, et al. Bilateral occipital calcification, epilepsy and celiac disease: case report [Article in Portuguese.]. Arq Neuropsiquiatr. 2002;60:840–3.PubMedCrossRefGoogle Scholar
  458. 458.
    Sasaki M, Ishii A, Saito Y, et al. Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology. 2014;82:482–90.PubMedCrossRefGoogle Scholar
  459. 459.
    Savitsky N, Tarachow S. Lilliputian hallucinations during convalescence of scarlet fever. J Nerv Ment Dis. 1941;93:310–2.CrossRefGoogle Scholar
  460. 460.
    Sawamura H, Yamamoto T, Ohtomo R, Bannai T, Wakakura M, Tsuji S. Anti-NMDA receptor encephalitis associated with transient cerebral dyschromatopsia, prosopagnosia, and lack of stereopsis. J Neuroophthalmol. 2014;34:144–8.PubMedCrossRefGoogle Scholar
  461. 461.
    Saygi S, Alehan F, Erol I, Yalcın YY, Ataç FB, Kubat G. TGF-β1 genotype in pediatric migraine patients. J Child Neurol. 2014, in press.Google Scholar
  462. 462.
    Schankin CJ, Maniyer FH, Digre KB, Goadsby PJ. ‘Visual snow’—a disorder distinct from persistent migraine aura. Brain. 2014;137:1419–24.PubMedCrossRefGoogle Scholar
  463. 463.
    Schankin CJ, Naniyer FH, Sprenger T, Chou DE, Eller M, Goadsby PJ. The relation between migraine, typical migraine aura and “visual snow.” Headache. 2014;54:957–66.Google Scholar
  464. 464.
    Schlaegel Jr TF, Quilala FV. Hysterical amblyopia. Arch Ophthalmol. 1955;54:875–84.CrossRefGoogle Scholar
  465. 465.
    Schreier HA, Libow JA. Munchausen by proxy syndrome: a modern pediatric challenge. J Pediatr. 1994;125:S110–5.PubMedCrossRefGoogle Scholar
  466. 466.
    Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J AAPOS. 1998;2:310–3.PubMedCrossRefGoogle Scholar
  467. 467.
    Scott JA, Egan RA. Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol. 2003;135:670–5.PubMedCrossRefGoogle Scholar
  468. 468.
    Scully R, Mark E, McNeely W, et al. Case Records of the Massachusetts General Hospital. Case 39–1998—a 13-year-old girl with a relapsing-remitting neurological disorder. N Engl J Med. 1998;339:1914–23.CrossRefGoogle Scholar
  469. 469.
    Selby G. Migraine and Its Variants. Sydney: Adis Health Science Press; 1983. p. 33.Google Scholar
  470. 470.
    Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;23:23–32.PubMedPubMedCentralCrossRefGoogle Scholar
  471. 471.
    Selhorst JB, Saul RF, Waybright EA. Optic nerve conduction: opposing effects of exercise and hyperventilation. Trans Am Neurol Assoc. 1981;106:101–5.Google Scholar
  472. 472.
    Seybold ME, Rosen PN. Peripapillary staphyloma and amaurosis fugax. Ann Ophthalmol. 1977;9:1139–41.PubMedGoogle Scholar
  473. 473.
    Shaikh S, Trese MT. New insights into progressive visual loss in adult retinopathy of prematurity. Arch Ophthalmol. 2004;122:404–6.PubMedCrossRefGoogle Scholar
  474. 474.
    Shams PN, Plant GT. Migraine-like visual aura due to focal cerebral lesions: case series and review. Surv Ophthalmol. 2011;56:135–61.PubMedCrossRefGoogle Scholar
  475. 475.
    Shepherd AJ. Colour vision in migraine: selective deficits for S-cone discriminations. Cephalalgia. 2005;25:412–23.PubMedCrossRefGoogle Scholar
  476. 476.
    Shutter LA, Green JP, Newman NJ, Hooks MA, Gordon RD. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology. 1993;43:2417–8.PubMedCrossRefGoogle Scholar
  477. 477.
    Silberstein S, Lenz R. Therapeutic monoclonal antibodies: What headache specialists need to know. Headache. 2015;55:1171–82.Google Scholar
  478. 478.
    Simpson JC, Goadsby PJ, Prabhakar P. Positive persistent visual symptoms (visual snow) presenting as a migraine variant in a 12-year-old girl. Pediatr Neurol. 2013;49:361–3.PubMedCrossRefGoogle Scholar
  479. 479.
    Singhi S, Jacobs H, Gladstein J. Pediatric headache: where have we been and where do we need to be. Headache. 2014;54:817–29.PubMedCrossRefGoogle Scholar
  480. 480.
    Sitko KR, Peragallo JH, Bidot S, et al. Pitfalls in the use of stereoacuity in the diagnosis of organic visual loss. Ophthalmology. 2016;123:198–202.Google Scholar
  481. 481.
    Smith TJ, Baker RS. Perimetric findings in functional disorders using automated techniques. Ophthalmology. 1987;94:1562–6.PubMedCrossRefGoogle Scholar
  482. 482.
    Snebold NG, Rizzo JF, Lessell S, et al. Transient visual loss in ornithine transcarbamoylase deficiency. Am J Ophthalmol. 1987;104:407–12.PubMedCrossRefGoogle Scholar
  483. 483.
    Solomon GD. Migrainous periorbital ecchymosis. Headache. 1989;29:328. Abstract.Google Scholar
  484. 484.
    Somerville BW. Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust. 1976;1:865–6.PubMedGoogle Scholar
  485. 485.
    Song H, Rossi EA, Latchney L, et al. Cone and rod loss in Stargardt disease revealed by adaptive optics scanning light ophthalmoscopy. JAMA Ophthalmol. 2015, in press.Google Scholar
  486. 486.
    Sørensen JB, Parnas J. A clinical study of 44 patients with juvenile amaurotic familial idiocy. Acta Psychiatr Scand. 1979;59:449–61.PubMedCrossRefGoogle Scholar
  487. 487.
    Sprenger T, Magon S. Can functional magnetic resonance imaging at rest shed light on the pathophysiology of migraine? Headache. 2013;53:723–5.PubMedCrossRefGoogle Scholar
  488. 488.
    Steg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology. 1991;141:1156.CrossRefGoogle Scholar
  489. 489.
    Steinberg H. Erythropoietin and visual hallucinations. N Engl J Med. 1991;325:285.PubMedGoogle Scholar
  490. 490.
    Stellingwerf C. Charles Bonnet Syndrome in Children. Vilamoura: European Paediatric Ophthalmological Society; 2006.Google Scholar
  491. 491.
    Stommel JE, Ward TN, Harris RD. MRI findings in a case of ophthalmoplegic migraine. Headache. 1993;33:234–7.PubMedCrossRefGoogle Scholar
  492. 492.
    Stone J, La France WC, Levenson Jr JL, Sharpe M. Issues for DSM-5: conversion disorder. Am J Psychiatry. 2010;167:626–7.PubMedCrossRefGoogle Scholar
  493. 493.
    Stone EM, Nichols BE, Kimura AE, Weingeist TA, Drack A, Sheffield VC. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol. 1994;112:765–72.PubMedCrossRefGoogle Scholar
  494. 494.
    Strauss H. Paroxysmal blindness. Electroencephalogr Clin Neurophysiol. 1963;15:921. Abstract.CrossRefGoogle Scholar
  495. 495.
    Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007;4:267–73.PubMedCrossRefGoogle Scholar
  496. 496.
    Swainman KF, Frank Y. Seizure headaches in children. Dev Med Child Neurol. 1978;20:580–5.CrossRefGoogle Scholar
  497. 497.
    Taich A, Crowe S, Kosmorsky GS, Traboulsi EI. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J AAPOS. 2004;8:457–61.PubMedCrossRefGoogle Scholar
  498. 498.
    Takano T, Tian G-F, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007;10:754–62.PubMedCrossRefGoogle Scholar
  499. 499.
    Tamhankar MA, Coslett HB, Fisher MJ, Sutton LN, Liu GT. Alexia without agraphia following biopsy of a left thalamic tumor. Pediatr Neurol. 2004;30:140–2.PubMedCrossRefGoogle Scholar
  500. 500.
    Tandon A, Branson HM, Buncic JR. Transient visual loss and isolated disk edema in juvenile nasopharyngeal angiofibroma. J AAPOS. 2010;14:90–2.PubMedCrossRefGoogle Scholar
  501. 501.
    Tarantino S, Capuano A, Torriero R, et al. Migraine equivalents as part of migraine syndrome in childhood. Pediatr Neurol. 2014;51:645–9.PubMedCrossRefGoogle Scholar
  502. 502.
    Tasman W, Brown GC. Progressive visual loss in adults with retinopathy of prematurity (ROP). Trans Am Ophthalmol Soc. 1988;86:367–79.PubMedPubMedCentralGoogle Scholar
  503. 503.
    Taylor D, Avetisov ES. Pediatric Ophthalmology. Boston: Blackwell Publications; 1990. p. 568–9.Google Scholar
  504. 504.
    Terwindt GM, Ophoff RA, van Eijk R, et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology. 2001;56:1028–32.PubMedCrossRefGoogle Scholar
  505. 505.
    Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migraves) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia. 1984;4:107–11.PubMedCrossRefGoogle Scholar
  506. 506.
    Thompson HS. Functional visual loss. Am J Ophthalmol. 1985;100:209–13.PubMedCrossRefGoogle Scholar
  507. 507.
    Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology. 2003;60:595–601.PubMedCrossRefGoogle Scholar
  508. 508.
    Tietjen GE. Migraine as a systemic disorder. Neurology. 2007;68:1555–6.PubMedCrossRefGoogle Scholar
  509. 509.
    Tippin J, Corbett JJ, Kerber RE, Schroeder E, Thompson HS. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol. 1989;26:69–77.PubMedCrossRefGoogle Scholar
  510. 510.
    Todd J. The syndrome of Alice in Wonderland. Can Med Assoc J. 1955;73:701–4.PubMedPubMedCentralGoogle Scholar
  511. 511.
    Toldo I, Pinello L, Suppiej A, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuroophthalmol. 2010;30:26–30.PubMedCrossRefGoogle Scholar
  512. 512.
    Tomsak RL, Jergens PB. Benign recurrent transient monocular blindness: a possible variant of acephalgic migraine. Headache. 1987;27:66–9.PubMedCrossRefGoogle Scholar
  513. 513.
    Törnqvist G. Paralysis of accommodation. Acta Ophthalmol (Copenh). 1971;49:702–6.CrossRefGoogle Scholar
  514. 514.
    Troost BT, Mark LE, Maroon JC. Resolution of classic migraine after removal of an occipital lobe AVM. Ann Neurol. 1979;5:199–201.PubMedCrossRefGoogle Scholar
  515. 515.
    Troost BT, Newton TH. Occipital lobe arteriovenous malformations: clinical and radiological features in 26 cases with comments on differentiation from migraine. Arch Ophthalmol. 1975;93:250–65.PubMedCrossRefGoogle Scholar
  516. 516.
    Tsao C-Y. Cerebellar ataxia, vertical supranuclear gaze palsy, sensorineural deafness, epilepsy, dementia, and hallucinations in an adolescent male. Semin Pediatr Neurol. 2014;21:106–8.PubMedCrossRefGoogle Scholar
  517. 517.
    Uliss AE, Moore AT, Bird AC. The dark choroid in posterior retinal dystrophies. Ophthalmology. 1987;94:1423–7.PubMedCrossRefGoogle Scholar
  518. 518.
    Underwood E. A shot at migraine. Science. 2016;351:116–9.Google Scholar
  519. 519.
    Uneri A, Turkdogan D. Evaluation of vestibular functions in children with vertigo attacks. Arch Dis Child. 2003;88:510–1.PubMedPubMedCentralCrossRefGoogle Scholar
  520. 520.
    van Balen AT, Slijper FE. Psychogenic amblyopia in children. J Pediatr Ophthalmol Strabismus. 1978;15(3):164–7.PubMedGoogle Scholar
  521. 521.
    van Bogaert L. L’hallucinose pedunculaire. Rev Neurol. 1927;43:608–17.Google Scholar
  522. 522.
    van de Ven RCG, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AMJM, Ferrari MD. Genetic models of migraine. Arch Neurol. 2007;64:643–6.PubMedCrossRefGoogle Scholar
  523. 523.
    van Gelder P, Geurs P, Kho GS, Dippel DW, Vecht CJ, Splinter TA. Cortical blindness and seizures following cisplatin treatment: both of epileptic origin? Eur J Cancer. 1993;29A:1497–8.PubMedCrossRefGoogle Scholar
  524. 524.
    van Harreveld A. The nature of the chick’s magnesium sensitive retinal spreading depression. J Neurobiol. 1984;15:333–44.PubMedCrossRefGoogle Scholar
  525. 525.
    Van Harreveld A. Two mechanisms for spreading depression in the chicken retina. J Neurobiol. 1978;6:419–31.CrossRefGoogle Scholar
  526. 526.
    Van Lith GHM. General cone dysfunction without achromatopsia. In: Pearlman JT, editor. 10th ISCERG symposium—color vision deficiencies. XII. Amsterdam: Kluwer Academic Publishers; 1995. p. 203–10.Google Scholar
  527. 527.
    Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007;68:1563–70.PubMedCrossRefGoogle Scholar
  528. 528.
    Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache. 2004;44:642–51.PubMedCrossRefGoogle Scholar
  529. 529.
    Vijayan N. Ophthalmoplegic migraine: ischemic or compressive neuropathy? Headache. 1980;20:300–4.PubMedCrossRefGoogle Scholar
  530. 530.
    Vike J, Jabbari B, Maitland CG. Auditory-visual synesthesia: report of a case with intact visual pathways. Arch Neurol. 1984;41:680–1.PubMedCrossRefGoogle Scholar
  531. 531.
    von Brevern M, Zeise D, Neuheuser H, Clarke AH, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128:365–74.CrossRefGoogle Scholar
  532. 532.
    von Noorden GK. Idiopathic amblyopia. Am J Ophthalmol. 1985;100:214–7.CrossRefGoogle Scholar
  533. 533.
    Walsh JP, O’Doherty DS. A possible explanation of the mechanism of ophthalmoplegic migraine. Neurology. 1960;10:1079–84.PubMedCrossRefGoogle Scholar
  534. 534.
    Wang J, Spencer R, Leffler JN, Birch EE. Characteristics of peripapillary retinal nerve fiber layer in preterm children. Am J Ophthalmol. 2012;153:850–5.Google Scholar
  535. 535.
    Warrell RP, Berman E. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. J Clin Oncol. 1986;4:76–9.Google Scholar
  536. 536.
    Waxman SG. Clinical course and electrophysiology of multiple sclerosis. In: Waxman SG, editor. Functional Recovery in Neurological Disease. New York: Raven Press; 1988. p. 157–84.Google Scholar
  537. 537.
    Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–60.PubMedCrossRefGoogle Scholar
  538. 538.
    Weinberger LM, Grant FC. Visual hallucinations and their neuro-optical correlates. Arch Ophthalmol. 1940;23:166–99.CrossRefGoogle Scholar
  539. 539.
    Welch KMA. Drug therapy of migraine. N Engl J Med. 1993;329:1476–83.PubMedCrossRefGoogle Scholar
  540. 540.
    Welch KM, Barkley GL, Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. Neurology. 1993;43 Suppl 3:S21–5.PubMedGoogle Scholar
  541. 541.
    Welch KM, D’Andrea G, Tepley N, et al. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990;8:817–28.PubMedGoogle Scholar
  542. 542.
    Weleber RG. Stargardt’s macular dystrophy. Arch Ophthalmol. 1994;112:752–4.PubMedCrossRefGoogle Scholar
  543. 543.
    Weleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993;11:1531–42.CrossRefGoogle Scholar
  544. 544.
    Weleber RG, Shults WT. Digoxin retinal toxicity. Clinical and electrophysiological evaluation of a cone dysfunction syndrome. Arch Ophthalmol. 1981;99:1568–72.PubMedCrossRefGoogle Scholar
  545. 545.
    Weller CM, Leen WG, Neville BGR, et al. A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood. Cephalagia. 2014, in press.Google Scholar
  546. 546.
    Weller CM, Pelzer N, de Vries B, et al. Two novel SCN1A mutations identified in families with familial hemiplegic migraine. Cephalalgia. 2014;34:1062–9.PubMedCrossRefGoogle Scholar
  547. 547.
    Weller M, Wiedemann P. Visual hallucinations. An outline of etiological and pathogenetic concepts. Int Ophthalmol. 1989;13:193–9.PubMedCrossRefGoogle Scholar
  548. 548.
    Wertenbaker C, Gutman I. Unusual visual symptoms. Surv Ophthalmol. 1985;29:297–9.PubMedCrossRefGoogle Scholar
  549. 549.
    Wessman M, Kallela M, Kaunisto MA, et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet. 2002;70:652–62.PubMedPubMedCentralCrossRefGoogle Scholar
  550. 550.
    White CP, Jan JE. Visual hallucinations after acute visual loss in a young child. Dev Med Child Neurol. 1992;34:259–61.PubMedCrossRefGoogle Scholar
  551. 551.
    Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural blood vessel diameter in the anaesthetized rat. Cephalalgia. 1997;17:518–24.PubMedCrossRefGoogle Scholar
  552. 552.
    Williamson PD, Boone PA, Spencer DD, et al. Occipital and parietal epilepsy. Epilepsy. 1988;29:682.Google Scholar
  553. 553.
    Williamson PD, Thadani VM, Darcy TM, Spencer DD, Spencer SS, Mattson RH. Occipital lobe epilepsy: clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol. 1992;31:3–13.PubMedCrossRefGoogle Scholar
  554. 554.
    Winterkorn JM. “Retinal Migraine” is an oxymoron. J Neuroophthalmol. 2007;27:1–2.PubMedCrossRefGoogle Scholar
  555. 555.
    Winterkorn JM. Vasospasm or migraine? Presented at the American Academy of Ophthalmology, San Francisco; November 1994.Google Scholar
  556. 556.
    Winterkorn JM, Burde RM. Vasospasm—not migraine—in the anterior visual pathway. Ophthalmol Clin North Am. 1996;9:393–405.Google Scholar
  557. 557.
    Winterkorn J, Kupersmith MJ, Wirtschafter JD, Forman S. Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329:396–8.PubMedCrossRefGoogle Scholar
  558. 558.
    Wirrell EC, Hamiwka LD, Hamiwka LA, Grisaru S, Wei X. Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci. 2007;34:316–21.PubMedCrossRefGoogle Scholar
  559. 559.
    Wisotsky BJ, Engel HM. Transesophageal echocardiography in the diagnosis of branch retinal artery obstruction. Am J Ophthalmol. 1993;115:653–6.PubMedCrossRefGoogle Scholar
  560. 560.
    Wolff HG. Headache and Other Head Pain. 2nd ed. New York: Oxford University Press; 1963.Google Scholar
  561. 561.
    Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689–92.PubMedCrossRefGoogle Scholar
  562. 562.
    Wraith E. Ornithine carbamoyltransferase deficiency. Arch Dis Child. 2001;84:84–8.PubMedPubMedCentralCrossRefGoogle Scholar
  563. 563.
    Wright Jr JD, Boger 3rd WP. Visual complaints from healthy children. Surv Ophthalmol. 1999;44:113–21.PubMedCrossRefGoogle Scholar
  564. 564.
    Wu W-C, Lin R-I, Shih C-P. Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology. 2012;119:1907–16.PubMedCrossRefGoogle Scholar
  565. 565.
    Wunderlich G, Suchan B, Volkmann J, Herzog H, Hömberg V, Seitz RJ. Visual hallucinations in recovery from cortical blindness: imaging correlates. Arch Neurol. 2000;57:561–5.PubMedCrossRefGoogle Scholar
  566. 566.
    Wynick S, Hobson RP, Jones RB. Psychogenic disorders of vision in childhood (“visual conversion reactions”): perspectives from adolescence: a research note. J Child Psychol Psychiatry. 1997;38:375–9.PubMedCrossRefGoogle Scholar
  567. 567.
    Yasuna ER. Hysterical amblyopia in children. Am J Dis Child. 1963;106:558–63.PubMedGoogle Scholar
  568. 568.
    Xi Q, Li L, Traboulsi EI, Wang QK. Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease. Mol Vis. 2009;15:638–45.PubMedPubMedCentralGoogle Scholar
  569. 569.
    Yanni SE, Wang J, Chan M, et al. Foveal avascular zone and foveal pit formation after preterm birth. Br J Ophthalmol. 2012;96:961–6.PubMedCrossRefGoogle Scholar
  570. 570.
    Yenice Ö, Onal S, Incili B, Temel A, Afşar N, Tanridağ T. Assessment of spatial-contrast function and short-wavelength sensitivity deficits in patients with migraine. Eye. 2007;21:218–23.PubMedCrossRefGoogle Scholar
  571. 571.
    Yorns Jr WR, Hardison HH. Mitochondrial dysfunction in migraine. Semin Pediatr Neurol. 2013;20:188–93.PubMedCrossRefGoogle Scholar
  572. 572.
    Younkin D. Topirate in the treatment of pediatric migraine. Headache. 2002;42:456. Abstract.Google Scholar
  573. 573.
    Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitichondrial optic neuropathies—disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81–114.PubMedPubMedCentralCrossRefGoogle Scholar
  574. 574.
    Zemen W, Donahue S, Dyken P, et al. The neuronal ceroid lipofuscinosis (Batten-Vogt syndrome). In: Vinken PJ, Bruyn GW, editors. Leukodystrophies and Polio Dystrophies. Handbook of Clinical Neurology, vol. 10. New York: American Elsevier; 1970. p. 588–679.Google Scholar
  575. 575.
    Zenker G, Erbel R, Krämer G, et al. Transesophageal two-dimensional echocardiography in young patients with cerebral ischemic events. Stroke. 1988;19:345–8.PubMedCrossRefGoogle Scholar
  576. 576.
    Zhang K, Bither PP, Park R, Donoso LA, Seidman JG, Seidman CE. A dominant Stargardt’s macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol. 1994;112:759–64.PubMedCrossRefGoogle Scholar
  577. 577.
    Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Mason J. Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol. 1987;44:486–9.PubMedCrossRefGoogle Scholar
  578. 578.
    Zung A, Margalith D. Ictal cortical blindness: a case report and review of the literature. Dev Med Child Neurol. 1993;35:921–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media New York 2016

Authors and Affiliations

  • Michael C. Brodsky
    • 1
  1. 1.Mayo ClinicRochesterUSA

Personalised recommendations